Under the agreement Medacta has a non-exclusive license to Mighty Oak’s patents related to the pedicle screw guides. Medacta also agreed to sell its MySpine Guides exclusively with Medacta pedicle screws through 2031.
“We are pleased to have resolved the ongoing litigation with Medacta and are excited to re-focus all internal resources on developing the next generation of presurgical planning and patient-specific solutions to enhance patient care,” Nick Byrne, Mighty Oak Medical vice president of sales and marketing, said in the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
